JAK2 and myeloproliferative disorder: In addition, JAK2 is the overlapping gene, and disregulation of the IL6/JAK2/STAT3 signalling pathways can lead to increased cellular proliferation and myeloproliferative neoplasms of hematopoietic stem cells.